Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 25, 1999
Sample size estimation in phase III cancer clinical trialsD Curran, R J Sylvester, G Hoctin BoesClinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
The effects of neoadjuvant anastrozole (Arimidex) on tumor volume in postmenopausal women with breast cancer: a randomized, double-blind, single-center studyJ M Dixon, L Renshaw, C Bellamy, et al.The Lancet. Oncology|August 5, 2006
Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial, A Buzdar, A Howell, et al.Gut|December 1, 1995
Identifying patients with a high risk of relapse in quiescent Crohn's disease. The GETAID Group. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires DigestivesT Sahmoud, G Hoctin-Boes, R Modigliani, et al.Lancet (London, England)|January 11, 2005
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancerA Howell, J Cuzick, M Baum, et al.British Journal of Cancer|May 29, 2008
Phase I pharmacokinetic and pharmacodynamic study of the prenyl transferase inhibitor AZD3409 in patients with advanced cancerN M G M Appels, M J Bolijn, K Chan, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 2001
[Platinum compounds in cancer therapy--past, present, and future]H Akaza, N Saijo, K Aiba, et al.Gynecologic Oncology|May 24, 2001
Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of CancerH C Wagenaar, N Colombo, I Vergote, et al.Pageof 1